CompletedPhase 2NCT00556439

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Principal Investigator
Carol A. Langford, MD, MHS, MD
The Cleveland Clinic
Intervention
Abatacept(drug)
Enrollment
97 enrolled
Eligibility
15 years · All sexes
Timeline
20082015

Study locations (10)

Collaborators

The Cleveland Clinic · Office of Rare Diseases (ORD) · Rare Diseases Clinical Research Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00556439 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials